오가노이드 및 스페로이드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Organoids And Spheroids Market size is expected to reach USD 11.62 Billion in 2034 from USD 2.36 Billion (2025) growing at a CAGR of 19.36% during 2026-2034.

The Global Organoids and Spheroids Market is expanding rapidly due to growing demand for advanced 3D cell culture models in research and drug development. Organoids and spheroids provide more accurate representations of human tissues compared to traditional 2D models. Increasing focus on personalized medicine and cancer research is driving adoption. Pharmaceutical companies are utilizing these models for preclinical testing and toxicity assessment.

Key growth drivers include advancements in stem cell research and regenerative medicine. Rising investments in biotechnology and academic research institutions are supporting innovation. The need to reduce reliance on animal testing is further encouraging the use of 3D cell culture systems. Additionally, collaborations between research organizations and biotech firms are accelerating market development.

Looking ahead, the market is expected to benefit from technological improvements in microfluidics and bioengineering. Integration with AI-driven drug discovery platforms will enhance research efficiency. Emerging markets are gradually increasing research funding, creating additional growth opportunities. As precision medicine evolves, the organoids and spheroids market is poised for strong long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Organoids
• Spheroids

By Application

• Developmental Biology
• Personalized Medicine
• Regenerative Medicine
• Disease Pathology Studies
• Drug Toxicity & Efficacy Testing

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospital & Diagnostic Centers

COMPANIES PROFILED

• STEMCELL Technologies Inc, Corning Incorporated, Merck KGaA, Greiner BioOne International GmbH, InSphero AG, Promega Corporation, Thermo Fisher Scientific Inc, Lonza Group Ltd, Prellis Biologics Inc, AMSBIO LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORGANOIDS AND SPHEROIDS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Organoids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Spheroids Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORGANOIDS AND SPHEROIDS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Developmental Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Disease Pathology Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Drug Toxicity & Efficacy Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORGANOIDS AND SPHEROIDS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospital & Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORGANOIDS AND SPHEROIDS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ORGANOIDS AND SPHEROIDS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 STEMCELL Technologies Inc
  • 9.2.2 Corning Incorporated
  • 9.2.3 Merck KGaA
  • 9.2.4 Greiner Bio-One International GmbH
  • 9.2.5 InSphero AG
  • 9.2.6 Promega Corporation
  • 9.2.7 Thermo Fisher Scientific Inc
  • 9.2.8 Lonza Group Ltd
  • 9.2.9 Prellis Biologics Inc
  • 9.2.10 AMSBIO LLC